Filing Details
- Accession Number:
- 0001053369-14-000027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-17 19:09:23
- Reporting Period:
- 2014-03-11
- Filing Date:
- 2014-03-17
- Accepted Time:
- 2014-03-17 18:09:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1053369 | Elite Pharmaceuticals Inc | ELTP | Pharmaceutical Preparations (2834) | 223542636 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1465822 | Jeenarine Narine | C/O Epic Pharma, Llc 227-15 North Conduit Avenue Laurelton NY 11413 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-03-11 | 239,367 | $0.60 | 14,887,229 | No | 4 | S | Indirect | By Epic Investments, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Epic Investments, LLC |
Footnotes
- Jeenarine Narine is an equity owner and executive officer of each of Epic Investments, LLC (EI)and Epic Pharma, LLC (EP), which is a 10% owner of the issuer, and also serves as a director of the issuer.
- Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.